U.S. markets close in 4 hours 30 minutes

RAMM Pharma Corp. (RAMMF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.05500.0000 (0.00%)
As of 01:58PM EDT. Market open.

RAMM Pharma Corp.

200, 82 Richmond St. East
Toronto, ON M5C 1P1

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Jackie Peter BurnettPres, CEO & Chairman495.68kN/AN/A
Mr. Guillermo Martin DelmonteCOO, Interim CFO & Corp. Sec. (Leave of Absence)271.46kN/AN/A
Mr. Jose RoldanInterim CFON/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, and nutraceutical products in Uruguay, Italy, Poland, Brazil, and internationally. The company also engages in the resale of medical supplies products; and sale of medical devices and consumables, and veterinarian products. It offers XALEX, a prescription pharmaceutical formulation for the treatment of refractory epilepsy; Cannabipiel Nite, Cannabipiel Body Lotion, Cannabipiel Hair Conditioner, Cannabipiel Liquid Soap, Cannabipiel Tite, Cannabipiel Cleaning Emulsion, Cannabipiel Shampoo, Cannabipiel Lite, and Cannabipiel Facial Tonic; and NETTAVET, a cannabis-based oral solution for dogs. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.

Corporate Governance

RAMM Pharma Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.